Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

Rosiglitazone may be useful for the treatment of antiretroviral therapy-associated lipoatrophy, but an association with cardiovascular disease (CVD) has been questioned in diabetics. We evaluated rosiglitazone's effect on surrogate markers of CVD in HIV-infected individuals with lipoatrophy. HI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tungsiripat, Marisa, El-Bejjani, Dalia, Rizk, Nesrine, Dogra, Vikram, O'Riordan, Mary Ann, Ross, Allison C., Hileman, Corrilynn, Storer, Norma, Harrill, Danielle, McComsey, Grace A.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2011
Assuntos:
Preclinical Studies/Drug Development
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064528/
https://ncbi.nlm.nih.gov/pubmed/20969457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2010.0187
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados